Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PETS

Petmed Express, Inc

Feb 13 • 04:00PM ET

3.18

+0.25 8.53 %

Healthcare • Pharmaceutical Retailers • USA • NASD

Peers: WOOF IDXX ZTS ELAN HSIC PDCO CVS WMT AMZN WBA

| Held by: VTI VXF ITOT BSVO DFAS FSCC DFSV IWC DFAT AVSC

Index	-	P/E	-	EPS (ttm)	-3.12	Insider Own	28.59%	Shs Outstand	21.38M	Perf Week	10.42%
Market Cap	68.05M	Forward P/E	-	EPS next Y	-	Insider Trans	1.68%	Shs Float	15.28M	Perf Month	-8.88%
Enterprise Value	41.80M	PEG	-	EPS next Q	-	Inst Own	34.17%	Short Float	6.80%	Perf Quarter	9.66%
Income	-64.87M	P/S	0.37	EPS this Y	-	Inst Trans	-0.42%	Short Ratio	0.39	Perf Half Y	2.58%
Sales	182.67M	P/B	2.08	EPS next Y	-	ROA	-55.74%	Short Interest	1.04M	Perf YTD	-0.62%
Book/sh	1.53	P/C	2.53	EPS next 5Y	-	ROE	-100.61%	52W High	4.53 -29.80%	Perf Year	-28.86%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	- -	ROIC	-196.97%	52W Low	1.57 102.55%	Perf 3Y	-84.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-6.02% -4.39%	Gross Margin	25.28%	Volatility	9.71% 5.13%	Perf 5Y	-91.43%
Dividend TTM	-	EV/Sales	0.23	EPS Y/Y TTM	-19236.81%	Oper. Margin	-15.90%	ATR (14)	0.19	Perf 10Y	-80.60%
Dividend Ex-Date	Aug 11, 2023	Quick Ratio	0.66	Sales Y/Y TTM	-26.05%	Profit Margin	-35.51%	RSI (14)	53.03	Recom	5.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.89	EPS Q/Q	-1364.43%	SMA20	1.00%	Beta	0.73	Target Price	2.75
Payout	-	Debt/Eq	0.02	Sales Q/Q	-23.26%	SMA50	3.00%	Rel Volume	0.07	Prev Close	2.93
Employees	173	LT Debt/Eq	0.01	Earnings	Oct 27	SMA200	4.36%	Avg Volume	2.64M	Price	3.18
IPO	Apr 26, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	-250.00% -23.56%	Trades		Volume	186,845	Change	8.53%

Date	Action	Analyst	Rating Change	Price Target Change
May-25-23	Initiated	Lake Street	Buy	$20
Jan-20-22	Upgrade	Sidoti	Neutral → Buy	$32
Nov-18-21	Initiated	Morgan Stanley	Underweight	$25
Oct-01-21	Initiated	Jefferies	Hold	$28
Aug-05-21	Resumed	Credit Suisse	Underperform	$22
Jun-03-21	Downgrade	Sidoti	Buy → Neutral	$39
Mar-05-21	Upgrade	Sidoti	Neutral → Buy
Jan-27-21	Downgrade	Sidoti	Buy → Neutral
Aug-19-20	Upgrade	Sidoti	Neutral → Buy	$37 → $41
Apr-09-20	Downgrade	Sidoti	Buy → Neutral
Mar-12-20	Upgrade	Sidoti	Neutral → Buy	$31
Feb-24-20	Downgrade	Sidoti	Buy → Neutral
Aug-16-19	Upgrade	Craig Hallum	Sell → Hold
Aug-16-19	Downgrade	Craig Hallum	Buy → Hold
Jun-15-18	Initiated	CL King	Neutral
Aug-24-17	Upgrade	Sidoti	Neutral → Buy
Jul-24-17	Upgrade	Northcoast	Neutral → Buy
May-09-16	Upgrade	Craig Hallum	Sell → Hold
Feb-04-16	Initiated	Credit Suisse	Underperform
Jul-19-10	Reiterated	JMP Securities	Mkt Outperform	$23 → $21

Show Previous Ratings

Dec-19-25 05:02PM	PetMed: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Dec-16-25 12:04PM	Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express (Business Wire) +35.89%
Dec-11-25 09:45AM	PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited (GlobeNewswire) +68.36%
Dec-10-25 08:00AM	PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them (GlobeNewswire) +9.94%
Nov-26-25 04:05PM	PetMeds Extends Existing Shareholder Rights Plan (GlobeNewswire) +8.59%
08:00AM	Loading…
Nov-13-25 08:00AM	PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq (GlobeNewswire) -32.59%
Oct-27-25 05:30PM	Bed Bath & Beyond (BBBY) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Oct-20-25 08:30AM	PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair (GlobeNewswire)
Oct-14-25 04:15PM	PetMeds Files Form 10-K for Fiscal 2025 (GlobeNewswire)
Oct-10-25 08:38AM	PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman (PR Newswire)
Oct-08-25 04:05PM	PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-25-25 12:05PM	JD.com (JD) Surges 5.7%: Is This an Indication of Further Gains? (Zacks)
Sep-10-25 08:25AM	Chewy (CHWY) Meets Q2 Earnings Estimates (Zacks)
Aug-25-25 07:45AM	PDD Holdings Inc. Sponsored ADR (PDD) Q2 Earnings and Revenues Top Estimates (Zacks)
Aug-15-25 05:59AM	CFOs On the Move: Week ending Aug. 15 (CFO.com)
04:11PM	Loading…
Aug-12-25 04:11PM	PetMed Express, Inc. Announces Management Changes (GlobeNewswire)
Aug-08-25 08:30AM	Fusemachines Appoints Christine Chambers, Experienced Public Company CFO, as Chief Financial Officer (GlobeNewswire)
Jul-30-25 08:15AM	Etsy (ETSY) Q2 Earnings Miss Estimates (Zacks)
Jul-23-25 08:00AM	PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills (GlobeNewswire) +7.12%
Jul-03-25 08:30AM	PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
Jul-01-25 08:30AM	PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing (GlobeNewswire)
Jun-24-25 09:00AM	Wagmo Partners with PetMeds to Bring Everyday Pet Health Savings to Members (Business Wire)
Jun-16-25 08:30AM	PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 (GlobeNewswire)
Jun-10-25 06:02PM	Markets Keep Nudging Higher Ahead of Trade Deals, CPI (Zacks) -11.22%
04:05PM	PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call (GlobeNewswire)
07:30AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-09-25 09:16AM	Earnings To Watch: PetMed Express Inc (PETS) Reports Q4 2025 Result (GuruFocus.com)
May-27-25 04:05PM	PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call (GlobeNewswire)
08:10AM	PDD Holdings Inc. Sponsored ADR (PDD) Lags Q1 Earnings and Revenue Estimates (Zacks)
May-07-25 09:08AM	PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets (GlobeNewswire)
09:00AM	Loading…
Apr-11-25 09:00AM	PetMeds to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th (GlobeNewswire)
Apr-09-25 08:00AM	PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors (GlobeNewswire) +5.52%
Mar-07-25 04:30AM	Bear of the Day: PetMed Express (PETS) (Zacks)
Feb-11-25 07:05AM	Q3 2025 Petmed Express Inc Earnings Call (Thomson Reuters StreetEvents) -14.04%
02:05AM	PetMed Express Inc (PETS) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Feb-10-25 04:16PM	PetMed: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PetMeds Announces Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Feb-07-25 07:09AM	What To Expect From PetMed Express Inc (PETS) Q3 2025 Earnings (GuruFocus.com)
Jan-30-25 04:05PM	PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call (GlobeNewswire) -5.18%
Jan-07-25 08:00AM	PetMed Express, Inc. to Participate in the 27th Annual ICR Conference (GlobeNewswire) +5.93%
Dec-23-24 09:50AM	Here's Why PetMed (PETS) is a Strong Momentum Stock (Zacks)
Dec-05-24 09:50AM	Why PetMed (PETS) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-03-24 08:30AM	PetMeds Adopts Limited Duration Shareholder Rights Plan (GlobeNewswire) +9.19%
Nov-30-24 07:19PM	PetMed Express, Inc. (PETS): A Bear Case Theory (Insider Monkey)
Nov-14-24 10:00AM	PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner (Business Wire)
09:50AM	Here's Why PetMed (PETS) is a Strong Momentum Stock (Zacks)
Nov-07-24 04:05PM	PetMed Express, Inc. to Participate in the Sidoti Micro Cap Conference (GlobeNewswire) +35.78%
02:20AM	PetMed Express Inc (PETS) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Nov-06-24 04:48PM	PetMed: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	PetMeds Announces Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Nov-05-24 08:08AM	What To Expect From PetMed Express Inc (PETS) Q2 2025 Earnings (GuruFocus.com)
Oct-24-24 02:46PM	PetMed Express, Inc. (PETS): A Bull Case Theory (Insider Monkey)
08:00AM	PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call (GlobeNewswire)
Oct-09-24 09:50AM	Here's Why PetMed (PETS) is a Strong Momentum Stock (Zacks)
Sep-27-24 04:17PM	PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-23-24 09:50AM	Why PetMed (PETS) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-12-24 08:00AM	PetMed Express, Inc. Announces Appointment of Robyn D'Elia as Chief Financial Officer (GlobeNewswire) +5.60%
Aug-21-24 08:30AM	PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-07-24 12:45PM	Q1 2024 Petmed Express Inc Earnings Call (Thomson Reuters StreetEvents) -14.36%
Aug-06-24 05:41PM	PetMed: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	PetMeds® Announces Fiscal 2025 First Quarter Financial Results (GlobeNewswire)
Aug-05-24 04:05PM	PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer (GlobeNewswire)
Jul-23-24 08:00AM	PetMed Express, Inc. Sets Fiscal First Quarter 2025 Earnings Call (GlobeNewswire)
Jun-27-24 01:36PM	Chewy stock spikes, then retreats, after 'Roaring Kitty' posts cryptic picture of dog on X (Yahoo Finance)
01:36PM	Chewy stock spikes after 'Roaring Kitty' posts cryptic picture of dog on X (Yahoo Finance)
Jun-24-24 08:00AM	PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors (GlobeNewswire)
Jun-16-24 07:00AM	Money Pit Warning: 7 Stocks to Sell ASAP Before They Die (InvestorPlace)
Jun-12-24 08:02AM	PetMed Express, Inc. (NASDAQ:PETS) Q4 2024 Earnings Call Transcript (Insider Monkey) -11.46%
03:52AM	PetMed Express shares slump premarket after Q4 loss widens (Investing.com)
Jun-11-24 08:53PM	PETS Stock Earnings: PetMed Express Misses EPS, Misses Revenue for Q4 2024 (InvestorPlace) +12.14%
04:25PM	PetMed: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results (GlobeNewswire)
Jun-03-24 08:00AM	PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team (GlobeNewswire)
May-28-24 08:00AM	PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer (GlobeNewswire)
May-22-24 04:05PM	PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call (GlobeNewswire)
May-20-24 08:00AM	PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors (GlobeNewswire)
Apr-30-24 08:34AM	Trade of the Day: Bet on a Short Squeeze in PetMed Express (PETS) Stock (InvestorPlace)
Apr-29-24 10:25AM	PetMed Express Appoints Sandra Campos as Chief Executive, President (MT Newswires)
08:15AM	PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President (GlobeNewswire)
Apr-15-24 12:52PM	PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024 (InvestorPlace)
08:26AM	PetMed: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
08:16AM	PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement (GlobeNewswire)
Apr-04-24 01:45PM	3 IT Stocks on Short Sellers Radar: Is a Tech Reckoning Imminent (InvestorPlace)
Mar-18-24 03:44AM	7 Penny Stocks to Sell in March Before They Crash & Burn (InvestorPlace)
Mar-13-24 08:17AM	11 Oversold Healthcare Stocks To Buy Right Now (Insider Monkey)
Feb-28-24 06:00PM	3 Oversold Stocks Presenting a Value Opportunity (InvestorPlace)
Feb-22-24 04:21AM	13 Best Falling Stocks To Buy Right Now (Insider Monkey)
Feb-16-24 08:30AM	PetMeds to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds Credits to Three Local Animal Shelters (GlobeNewswire)
Feb-15-24 01:34PM	3 Hidden-Gem E-commerce Stocks Ready to Ride a Massive Market Wave (InvestorPlace)
08:30AM	PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q (GlobeNewswire)
Feb-14-24 01:47AM	Jim Simons Bolsters Position in PetMed Express Inc (GuruFocus.com)
Feb-09-24 09:26AM	PetMed Express, Inc. (NASDAQ:PETS) Q3 2024 Earnings Call Transcript (Insider Monkey)
06:05AM	Q3 2023 Petmed Express Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-08-24 04:56PM	PetMed Express Inc (PETS) Reports Growth Amidst Restatement of Financials (GuruFocus.com)
04:01PM	PetMeds Announces Selected Preliminary Third Quarter Financial Results (GlobeNewswire)
Jan-29-24 08:30AM	PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call (GlobeNewswire)
Jan-08-24 05:46PM	PetMeds Announces new Chairman of the Board (PR Newswire)
Dec-19-23 06:36PM	PetMed Express, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Dec-16-23 07:00AM	3 Penny Stocks That Are About to Get Absolutely Crushed (InvestorPlace)
Dec-08-23 04:35PM	PetMed Express, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Silvercape Investments Ltd	10% Owner	Aug 13 '25	Buy	3.17	101,000	320,170	2,579,696	Aug 14 08:40 AM
Silvercape Investments Ltd	10% Owner	Aug 01 '25	Buy	3.21	118,200	379,422	2,478,696	Aug 04 08:26 AM
NINA CAPITAL HOLDINGS INC.	10% Owner	Jul 21 '25	Buy	3.50	25,000	87,425	2,575,000	Jul 22 04:15 PM
Silvercape Investments Ltd	10% Owner	Jul 18 '25	Buy	3.23	17,565	56,735	2,360,496	Jul 21 08:13 AM
Silvercape Investments Ltd	10% Owner	Jul 17 '25	Buy	3.15	31,701	99,858	2,342,931	Jul 18 06:02 AM
Silvercape Investments Ltd	10% Owner	Jul 02 '25	Buy	3.22	2,817	9,071	2,311,230	Jul 03 10:19 AM
Silvercape Investments Ltd	10% Owner	Jul 01 '25	Buy	3.21	694	2,228	2,308,413	Jul 02 02:41 PM
NINA CAPITAL HOLDINGS INC.	10% Owner	Jun 03 '25	Buy	3.94	25,000	98,375	2,550,000	Jun 04 04:15 PM
NINA CAPITAL HOLDINGS INC.	10% Owner	May 21 '25	Buy	3.86	25,000	96,500	2,525,000	May 23 04:15 PM
Silvercape Investments Ltd	10% Owner	May 20 '25	Buy	3.95	7,401	29,234	2,307,719	May 22 10:55 AM
Campos Sandra Yvette	CEO & President	Apr 30 '25	Sale	3.31	60,463	200,090	578,524	May 02 08:57 PM
NINA CAPITAL HOLDINGS INC.	10% Owner	Mar 18 '25	Buy	4.08	100,000	408,500	2,500,000	Mar 19 04:19 PM
NINA CAPITAL HOLDINGS INC.	10% Owner	Mar 10 '25	Buy	4.11	100,000	411,000	2,400,000	Mar 11 04:15 PM
NINA CAPITAL HOLDINGS INC.	10% Owner	Mar 03 '25	Buy	4.33	50,000	216,250	2,300,000	Mar 04 04:16 PM

Open in Screener

CVS

CVS Health Corp

Feb 13 • 04:00PM ET

78.48

+0.55 0.71 %

Healthcare • Healthcare Plans • USA • NYSE

Peers: CI UNH CNC HUM MOH WBA MCK CAH TDOC WMT

| Held by: VTI VOO IVV SPY VTV XLV VYM DVY VHT FNDX

Index	S&P 500	P/E	56.72	EPS (ttm)	1.38	Insider Own	0.14%	Shs Outstand	1.27B	Perf Week	0.17%
Market Cap	99.84B	Forward P/E	9.59	EPS next Y	8.19	Insider Trans	-0.41%	Shs Float	1.27B	Perf Month	-1.07%
Enterprise Value	169.30B	PEG	0.81	EPS next Q	2.23	Inst Own	89.54%	Short Float	1.60%	Perf Quarter	-2.22%
Income	1.77B	P/S	0.25	EPS this Y	6.16%	Inst Trans	2.12%	Short Ratio	2.43	Perf Half Y	17.61%
Sales	402.11B	P/B	1.33	EPS next Y	14.23%	ROA	0.68%	Short Interest	20.35M	Perf YTD	-1.11%
Book/sh	59.18	P/C	9.37	EPS next 5Y	11.83%	ROE	2.35%	52W High	85.15 -7.83%	Perf Year	18.25%
Cash/sh	8.38	P/FCF	12.79	EPS past 3/5Y	-24.70% -23.94%	ROIC	1.18%	52W Low	58.35 34.50%	Perf 3Y	-12.67%
Dividend Est.	2.74 (3.49%)	EV/EBITDA	9.80	Sales past 3/5Y	7.60% 8.40%	Gross Margin	13.78%	Volatility	3.91% 3.43%	Perf 5Y	5.75%
Dividend TTM	2.66 (3.39%)	EV/Sales	0.42	EPS Y/Y TTM	-61.77%	Oper. Margin	3.15%	ATR (14)	2.57	Perf 10Y	-18.13%
Dividend Ex-Date	Jan 22, 2026	Quick Ratio	0.63	Sales Y/Y TTM	7.89%	Profit Margin	0.44%	RSI (14)	52.10	Recom	1.62
Dividend Gr. 3/5Y	5.74% 5.87%	Current Ratio	0.84	EPS Q/Q	76.77%	SMA20	1.15%	Beta	0.49	Target Price	95.17
Payout	191.23%	Debt/Eq	1.06	Sales Q/Q	8.38%	SMA50	0.04%	Rel Volume	0.80	Prev Close	77.93
Employees	300000	LT Debt/Eq	0.99	Earnings	Feb 10 BMO	SMA200	8.14%	Avg Volume	8.37M	Price	78.48
IPO	Oct 01, 1952	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.73% 1.92%	Trades		Volume	6,719,145	Change	0.71%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-14-25	Initiated	Goldman	Buy	$91
Aug-18-25	Upgrade	UBS	Neutral → Buy	$79
Aug-14-25	Upgrade	Robert W. Baird	Neutral → Outperform	$82
Feb-13-25	Upgrade	Leerink Partners	Market Perform → Outperform	$55 → $75
Feb-12-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jan-30-25	Upgrade	Edward Jones	Hold → Buy
Dec-03-24	Upgrade	Deutsche Bank	Hold → Buy	$66
Nov-18-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$60 → $66
Oct-10-24	Upgrade	Barclays	Equal Weight → Overweight	$63 → $82
Oct-04-24	Upgrade	TD Cowen	Hold → Buy	$59 → $85
May-30-24	Initiated	Robert W. Baird	Neutral	$61
May-07-24	Downgrade	TD Cowen	Buy → Hold	$99 → $59
May-02-24	Downgrade	UBS	Buy → Neutral	$85 → $60
May-01-24	Downgrade	Leerink Partners	Outperform → Market Perform	$87 → $60
May-01-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Mar-06-24	Initiated	Barclays	Equal Weight	$78
Feb-26-24	Initiated	Leerink Partners	Outperform	$88
Dec-22-23	Initiated	HSBC Securities	Buy	$94
Sep-19-23	Upgrade	Evercore ISI	In-line → Outperform	$81 → $83
Sep-12-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$80

Show Previous Ratings

Feb-13-26 07:53AM	Retirees and Income Investors Get Paid Monthly, Plus 20% Gains With This ETF (24/7 Wall St.)
Feb-12-26 12:37PM	This Is Gracos Dividend Score After Paying Investors (24/7 Wall St.)
11:07AM	Bank of America resets future estimates for CVS post earnings (TheStreet)
Feb-11-26 02:32PM	Analysts See Multiple Growth Levers For CVS In 2026 (Benzinga)
09:47AM	Humana Earnings Reveal Narrower-Than-Expected Loss. Why the Stock Is Falling. (Barrons.com)
07:04AM	Loading…
07:04AM	Humana Loss Was Narrower Than Expected. Why the Stock Is Falling. (Barrons.com)
04:58AM	Mark Cuban Urges Trump To 'Put His Weight Behind' Josh Hawley, Elizabeth Warren's 'Break Up Big Medicine Act' (Benzinga)
12:33AM	CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook (StockStory)
Feb-10-26 10:07PM	CVS Health Q4 Earnings Call Highlights (MarketBeat)
05:15PM	Humana Earnings Will Shed More Light on Medicare Prospects (Barrons.com)
04:31PM	CVS Health Corporation Q4 2025 Earnings Call Summary (Moby)
04:24PM	These Stocks Are Todays Movers: Spotify, S&P Global, CVS, Coca-Cola, TSMC, Datadog, Kyndryl, Credo, and More (Barrons.com)
04:23PM	Stocks to Watch Tuesday: Netflix, Coca-Cola, CVS, Target (The Wall Street Journal)
04:11PM	CVS Stock Falls After Earnings Beat. This Concern Remains. (Barrons.com)
04:03PM	Stock market today: Dow ekes out third straight record, S&P 500, Nasdaq slide with jobs report on deck (Yahoo Finance)
03:43PM	Loading…
03:43PM	Stock market today: Dow moves higher, S&P 500 and Nasdaq dip after weak retail sales fuel Fed cut bets (Yahoo Finance)
02:13PM	CVS Reiterates 2026 Profit Outlook, Shares Slide 3.7% Despite Q4 Beat (GuruFocus.com)
02:02PM	CVS Health Corp (CVS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:53PM	CVS Health Reaffirms Profit Outlook After Q4 Beat (Benzinga)
11:43AM	CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market (Zacks)
10:59AM	Jim Cramer on CVS: "I Think It's a Fascinating Time to Own the Stock" (Insider Monkey)
10:58AM	CVS Q4 earnings beat: A breakdown of the revenue & more (Yahoo Finance Video)
10:04AM	CVS Health posts strong Q4 revenue, raises full-year guidance (Proactive)
09:47AM	CVS's full-year results show the turnaround in action (Quartz)
09:47AM	CVS earnings show a turnaround in action as the stock rebounds (Quartz)
09:34AM	Stock market today: Dow, S&P 500, Nasdaq tick higher as earnings roll in, Wall Street braces for data deluge (Yahoo Finance)
09:34AM	Stock market today: Dow, S&P 500, Nasdaq rise as earnings flood in, weak retail sales lead off data deluge (Yahoo Finance)
09:34AM	Stock market today: Dow leads S&P 500, Nasdaq higher as earnings roll in, Wall Street braces for data deluge (Yahoo Finance)
09:30AM	CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:50AM	CVS Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
08:35AM	Loading…
08:35AM	The CVS Earnings Bombshell That Has Investors Scrambling Right Now (24/7 Wall St.)
08:15AM	Earnings live: Spotify stock jumps on subscriber growth, CVS earnings beat, BP halts stock buybacks (Yahoo Finance)
07:40AM	CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:24AM	CVS Stock Drops After Earnings Beat. Why Medicare Worries Persist. (Barrons.com)
07:19AM	CVS Health Q4 Beats Street, Confirms FY26 Earnings View; Stock Down (RTT News)
07:12AM	CVS Health beats Q4 expectations, cash flow guidance lowered (Investing.com)
06:53AM	CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist. (Barrons.com)
06:48AM	CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales (StockStory)
06:42AM	CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses (MarketWatch)
06:41AM	CVS Health: Q4 Earnings Snapshot (Associated Press Finance)
06:37AM	CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector (The Wall Street Journal)
06:34AM	CVS Health beats quarterly profit expectations on pharmacy performance (Reuters)
06:30AM	CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS (PR Newswire)
06:00AM	Robinhood earnings to highlight retail investor activity (MarketWatch)
04:27AM	Stock Market Today: Dow holds record high, S&P 500 and Nasdaq consolidate ahead of retail sales data; Robinhood earnings on tap. (MarketWatch)
Feb-09-26 07:55PM	Review & Preview: A Broadening Bull (Barrons.com)
11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
08:26AM	CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View (Insider Monkey)
06:23AM	Stocks Set for Muted Open as Bond Yields Climb, Key U.S. Economic Data Awaited (Barchart)
Feb-08-26 10:05PM	CVS Health (CVS) Q4 Earnings: What To Expect (StockStory)
02:00PM	Jobs, Consumer Prices, Coca-Cola, CVS, Ford, McDonald's, and More to Watch This Week (Barrons.com)
Feb-06-26 08:37PM	Layoffs surge just weeks into the new year (TheStreet)
04:08PM	CVS Pharmacy Now Accepting TrumpRx Discount Cards (PR Newswire)
01:52PM	CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder (Benzinga)
Feb-05-26 04:00PM	Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey (PR Newswire)
12:49PM	FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings (Benzinga)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
11:13AM	Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That. (Barrons.com)
09:15AM	What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings (Zacks)
08:01AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The StartPBM 'Spread Pricing' Comes Under Fire (Benzinga)
08:00AM	CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care (PR Newswire)
07:00AM	Aetna Launches Simplified, Digital-first, Benefits Onboarding Experience for Members in 2026 (PR Newswire)
Feb-04-26 05:45PM	CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
01:15PM	How UnitedHealth's Comeback Ran Aground (Barrons.com)
11:30AM	UnitedHealth's Comeback Runs Aground. Medicare Is Still a Problem. (Barrons.com)
08:47AM	Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings? (Zacks)
06:46AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The StartPBM 'Spread Pricing' Comes Under Fire (Benzinga)
Feb-03-26 04:49PM	Banco Santander Strikes $12.3 Billion Deal for Webster Financial in U.S. Expansion (The Wall Street Journal)
10:00AM	CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
07:55AM	CVS Health's (CVS) Path Forward: Policy Challenges, Analyst Views, and Dividend Stability (Insider Monkey)
03:08AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start-PBM 'Spread Pricing' Comes Under Fire (Benzinga)
Feb-02-26 07:15AM	Should Investors Buy, Sell or Hold Lilly Stock Ahead of Q4 Earnings? (Zacks)
05:47AM	Mark Cuban Says Berkshire Should Reconsider Insurance Bets: 'I Hate To Say This' (Benzinga)
Feb-01-26 05:30PM	Home Depot finds a new way to beat Lowe's (TheStreet)
Jan-31-26 09:35AM	CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts (Insider Monkey)
07:47AM	Argus Trims CVS Health (CVS) PT to $90 Amid Medicare Advantage Rate Uncertainty (Insider Monkey)
Jan-30-26 02:23PM	Should You Buy the Dip in These 2 Dividend Stocks? (Barchart)
09:40AM	Why CVS Health (CVS) is a Top Value Stock for the Long-Term (Zacks)
Jan-29-26 10:38AM	UnitedHealth Falls on Weak 2026 Outlook, Medicare Rate Cut (GuruFocus.com)
09:13AM	Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results (Zacks)
02:19AM	Trump's Flat Rate Medicare Advantage Proposal Is 'Shock To The System,' Risking 20% Earnings Hit, Delaying Healthcare Turnaround (Benzinga)
Jan-28-26 05:45PM	CVS Health (CVS) Ascends While Market Falls: Some Facts to Note (Zacks)
12:35PM	Elevance Health Earnings Add to Medicare Pain. Why The Stock Is Rising Anyway. (Barrons.com)
12:24PM	Stock Of The Day: Where Is The Bottom For CVS? (Benzinga)
12:07PM	UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs (Benzinga)
07:42AM	Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain. (Barrons.com)
05:30AM	Investors Assumed Medicare Advantage Was Safe Under the GOP. They Were Wrong. (The Wall Street Journal)
03:20AM	Heard on the Street Tuesday Recap: Medicare Disadvantage (The Wall Street Journal)
Jan-27-26 11:31PM	UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates (Benzinga) -14.15%
07:13PM	'Big Short' Is Long On Molina Healthcare Stock-Was He Big Wrong? (Benzinga)
07:06PM	S&P 500 marks closing record as corporate earnings roll in (Reuters Videos)
05:34PM	Heard on the Street Recap: Medicare Disadvantage (The Wall Street Journal)
05:33PM	Health Insurers in Shock After Medicare Holds Line on 2027 Payments (The Wall Street Journal)
05:12PM	Why shares of UnitedHealth, Humana and other insurers tanked - and took the Dow with them (MarketWatch)
04:54PM	Health Insurers Weigh on the Dow, While S&P 500 Sets Fresh Record (The Wall Street Journal)
04:44PM	Humana, UnitedHealth, CVS Stocks Tumble After Medicare Rates Blow (Barrons.com)
04:44PM	Humana, UnitedHealth, and CVS Stocks Plunge After Setback on Medicare Rates (Barrons.com)
04:41PM	UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isnt the Only Problem. (Barrons.com)
04:38PM	These Stocks Are Todays Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More (Barrons.com)
04:37PM	The Dow Is Getting Pummeled by UnitedHealth. Why the Rest of the Stock Market Is Fine. (Barrons.com)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Finucane Anne A.	Director	Aug 20 '25	Sale	71.02	7,500	532,650	22,156	Aug 29 04:29 PM
Finucane Anne A.	Director	Aug 20 '25	Proposed Sale	70.97	7,500	532,275		Aug 19 06:57 PM
SANSONE GUY P	Director	Jun 05 '25	Buy	63.70	1,570	100,009	12,007	Jun 09 08:22 AM
ROBBINS LARRY	Director	May 02 '25	Sale	67.86	2,276,068	154,444,758	9,670,731	May 06 04:15 PM
ROBBINS LARRY	Director	May 05 '25	Sale	67.41	1,323,932	89,249,945	8,346,799	May 06 04:15 PM
ROBBINS LARRY	Director	May 06 '25	Sale	66.67	150,000	10,000,710	8,196,799	May 06 04:15 PM
Shah Prem S	EVP and Group President	Mar 17 '25	Option Exercise	62.21	846	52,630	43,190	Mar 18 04:51 PM
Clark James David	SVP, Cont & Chief Acct Officer	Mar 05 '25	Option Exercise	62.21	7,513	467,384	15,907	Mar 07 04:56 PM
Clark James David	SVP, Cont & Chief Acct Officer	Mar 05 '25	Sale	66.35	7,513	498,488	8,394	Mar 07 04:56 PM
Clark James David	Officer	Mar 05 '25	Proposed Sale	66.35	7,513	498,489		Mar 05 05:25 PM
Mahoney Michael F	Director	Feb 18 '25	Buy	66.70	30,000	2,001,000	39,356	Feb 19 12:35 PM

BTSG BrightSpring Health Services Inc daily Stock Chart

Peers: EHC AMED ENSG CHE ADUS FMS HCSG SVC SSY OPI

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT IWO SLYG

Index	RUT	P/E	64.87	EPS (ttm)	0.60	Insider Own	36.39%	Shs Outstand	180.69M	Perf Week	-2.07%
Market Cap	7.01B	Forward P/E	29.11	EPS next Y	1.33	Insider Trans	-31.19%	Shs Float	114.72M	Perf Month	1.07%
Enterprise Value	9.57B	PEG	0.67	EPS next Q	0.35	Inst Own	82.03%	Short Float	7.20%	Perf Quarter	15.52%
Income	129.59M	P/S	0.56	EPS this Y	87.51%	Inst Trans	15.16%	Short Ratio	4.52	Perf Half Y	72.10%
Sales	12.41B	P/B	3.86	EPS next Y	27.12%	ROA	1.23%	Short Interest	8.25M	Perf YTD	3.77%
Book/sh	10.06	P/C	49.94	EPS next 5Y	43.36%	ROE	4.25%	52W High	41.26 -5.82%	Perf Year	76.00%
Cash/sh	0.78	P/FCF	21.95	EPS past 3/5Y	- 60.10%	ROIC	2.93%	52W Low	15.48 150.98%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	17.64	Sales past 3/5Y	18.93% 20.01%	Gross Margin	12.30%	Volatility	4.45% 4.26%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.77	EPS Y/Y TTM	371.04%	Oper. Margin	2.92%	ATR (14)	1.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	17.23%	Profit Margin	1.04%	RSI (14)	50.18	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	1.79	EPS Q/Q	641.65%	SMA20	-0.97%	Beta	2.41	Target Price	44.47
Payout	-	Debt/Eq	1.48	Sales Q/Q	14.70%	SMA50	2.00%	Rel Volume	0.71	Prev Close	37.79
Employees	600	LT Debt/Eq	1.43	Earnings	Feb 27 BMO	SMA200	34.90%	Avg Volume	1.82M	Price	38.86
IPO	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.07% 4.56%	Trades		Volume	1,290,418	Change	2.83%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-12-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$45
Dec-11-25	Initiated	Stephens	Overweight	$44
Dec-08-25	Initiated	William Blair	Outperform
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$40
Jun-23-25	Initiated	TD Cowen	Buy	$37
Dec-12-24	Initiated	CJS Securities	Market Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-21-24	Initiated	BTIG Research	Buy	$15
Mar-06-24	Initiated	HSBC Securities	Buy	$13
Feb-27-24	Upgrade	Deutsche Bank	Hold → Buy	$11.50
Feb-20-24	Initiated	Wells Fargo	Overweight	$15
Feb-20-24	Initiated	UBS	Buy	$15
Feb-20-24	Initiated	Morgan Stanley	Overweight	$18
Feb-20-24	Initiated	Leerink Partners	Outperform	$15
Feb-20-24	Initiated	Jefferies	Buy	$18
Feb-20-24	Initiated	Guggenheim	Buy	$15
Feb-20-24	Initiated	Goldman	Buy	$26
Feb-20-24	Initiated	Deutsche Bank	Hold	$11.50
Feb-20-24	Initiated	BofA Securities	Buy	$14

Show Previous Ratings

Feb-13-26 03:38PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes New Buy Point (Investor's Business Daily)
Feb-09-26 12:04PM	TIG Analyst Raises BrightSpring (BTSG) PT to $55, Cites Consistent Operational Performance (Insider Monkey)
Feb-05-26 11:03PM	2 Reasons to Like BTSG (and 1 Not So Much) (StockStory)
Feb-03-26 04:05PM	BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 (GlobeNewswire)
Jan-16-26 12:13PM	Mizuho Raises BrightSpring (BTSG) PT to $45 Despite Signs of Peak Healthcare Demand (Insider Monkey)
08:27AM	Loading…
Jan-08-26 08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
07:25AM	IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? (Zacks)
Jan-06-26 09:15AM	Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:12AM	Should Labcorp Stock Stay in Your Portfolio Right Now? (Zacks)
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Dec-31-25 04:09PM	Home Care Provider's Growth Impresses As 'Silver Tsunami,' Other Trends Drive Demand (Investor's Business Daily)
08:55AM	Loading…
08:55AM	Here's What Could Help BrightSpring Health Services, Inc. (BTSG) Maintain Its Recent Price Strength (Zacks)
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-26-25 11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
04:48AM	New Strong Buy Stocks for December 24th (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)
Dec-19-25 03:16PM	Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today (StockStory)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
09:09AM	Loading…
09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
Dec-18-25 03:11PM	BrightSpring Health Services (BTSG) Stock Is Up, What You Need To Know (StockStory)
08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-17-25 07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
07:55AM	Should You Retain Teleflex Stock in Your Portfolio Now? (Zacks)
Dec-16-25 03:47PM	The Best Value Stocks to Buy in 2026 (Zacks)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
07:47AM	TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
08:55AM	BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Dec-12-25 07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-10-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
Dec-08-25 07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-05-25 02:15PM	IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range (Investor's Business Daily)
08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-03-25 11:59AM	EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand (Zacks)
09:40AM	Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year? (Zacks)
09:34AM	Zacks.com featured highlights include Agnico Eagle Mines, General Motors, Great Lakes Dredge & Dock, BrightSpring Health Services and Everus Construction (Zacks)
Dec-02-25 12:10PM	GM and 4 Stocks With Relative Price Strength to Buy Now (Zacks)
Nov-30-25 09:35PM	BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions (Insider Monkey)
Nov-26-25 12:20PM	Earnings Estimates Moving Higher for BrightSpring Health Services, Inc. (BTSG): Time to Buy? (Zacks)
Nov-25-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-24-25 07:00PM	BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know (StockStory)
11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
08:13AM	5 Broker-Liked Stocks to Keep an Eye on Amid the Current Market Swings (Zacks)
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-19-25 12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-17-25 09:41AM	Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year? (Zacks)
Nov-15-25 11:42PM	UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3 (Insider Monkey)
Nov-13-25 10:34PM	Q3 Earnings Outperformers: BrightSpring Health Services (NASDAQ:BTSG) And The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory) -5.62%
Nov-07-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Nov-04-25 01:34PM	Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum? (Zacks)
12:36AM	The 5 Most Interesting Analyst Questions From BrightSpring Health Services's Q3 Earnings Call (StockStory)
Oct-30-25 09:25AM	What To Expect From BrightSpring Health Services Inc (BTSG) Q3 2025 Earnings (GuruFocus.com)
Oct-29-25 08:35AM	BTSG Q3 Deep Dive: Specialty Pharmacy and Infusion Growth Offset Customer Shifts (StockStory)
Oct-28-25 04:55PM	BrightSpring Health Services (NASDAQ:BTSG) Delivers Strong Q3 Numbers (StockStory)
04:05PM	BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
11:46AM	Implied Volatility Surging for BrightSpring Health Services Stock Options (Zacks)
Oct-26-25 11:11PM	BrightSpring Health Services (BTSG) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-24-25 12:32AM	1 Growth Stock Set to Flourishand 2 We Turn Down (StockStory)
Oct-20-25 09:20PM	BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase (GlobeNewswire) +5.84%
05:30PM	BrightSpring Health Services, Inc. (BTSG) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase (GlobeNewswire)
04:13PM	BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
Oct-15-25 02:01PM	Why BrightSpring Health Services (BTSG) Stock Is Up Today (StockStory)
Oct-14-25 06:00PM	BrightSpring Health Services Set to Join S&P SmallCap 600 (PR Newswire)
Oct-13-25 04:40PM	Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today (StockStory)
Oct-09-25 12:10PM	Can BrightSpring Health Services, Inc. (BTSG) Keep the Earnings Surprise Streak Alive? (Zacks)
Oct-08-25 04:05PM	BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025 (GlobeNewswire)
Oct-07-25 12:03AM	3 Reasons to Sell BTSG and 1 Stock to Buy Instead (StockStory)
Sep-20-25 09:40AM	BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets (Insider Monkey)
Sep-19-25 12:46AM	BofA Raises BrightSpring Health Services (BTSG) PT on BrightSpring Health to $31, Keeps a Buy Rating (Insider Monkey)
Sep-17-25 01:30AM	This Infusion Therapy Leader Is Undervalued. Buy the Stock. (Barrons.com)
Sep-11-25 02:15PM	Deutsche Bank Raises BrightSpring Health Services (BTSG) PT to $30 Following Strong Q2 Growth (Insider Monkey)
Sep-04-25 11:33PM	Senior Health, Home Health & Hospice Stocks Q2 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Firing on All Cylinders (StockStory)
Aug-15-25 04:00PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes Latest Buy Point (Investor's Business Daily)
Aug-13-25 12:02AM	BrightSpring Health Services's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Aug-12-25 11:51PM	BTSG Q2 Deep Dive: Specialty Pharmacy and Infusion Growth Shape Outlook Amid Market Caution (StockStory) +5.13%
Aug-06-25 10:19AM	Are Options Traders Betting on a Big Move in BrightSpring Health Services Stock? (Zacks)
Aug-05-25 12:00PM	BrightSpring Health Services, Inc. (BTSG) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:40AM	Are Medical Stocks Lagging Stryker (SYK) This Year? (Zacks)

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KKR Group Partnership L.P.	10% Owner	Oct 22 '25	Sale	28.78	14,745,000	424,390,590	62,351,337	Oct 22 05:52 PM
KKR Phoenix Aggregator L.P.	10% Owner	Oct 22 '25	Sale	28.78	14,745,000	424,390,590	62,351,337	Oct 22 05:48 PM
ROUSSEAU JON B	See Remarks	Oct 22 '25	Option Exercise	6.37	235,000	1,496,950	1,366,930	Oct 22 04:10 PM
ROUSSEAU JON B	See Remarks	Oct 22 '25	Sale	28.78	235,000	6,763,770	1,131,930	Oct 22 04:10 PM
Nalley Lisa A	See Remarks	Oct 22 '25	Option Exercise	6.37	20,000	127,400	151,150	Oct 22 04:09 PM
Nalley Lisa A	See Remarks	Oct 22 '25	Sale	28.78	20,000	575,640	131,150	Oct 22 04:09 PM
McMaude Michael A	Former Officer	Aug 14 '25	Proposed Sale	22.40	16,168	362,241		Aug 14 05:53 PM
KKR Group Partnership L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:31 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:30 PM
KKR Group Partnership L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Option Exercise	6.37	15,616	99,474	245,646	Jun 13 04:04 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Sale	21.75	15,616	339,648	230,030	Jun 13 04:04 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Option Exercise	6.37	14,415	91,824	145,565	Jun 13 04:03 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Sale	21.75	14,415	313,526	131,150	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Option Exercise	6.37	531,840	3,387,821	1,715,973	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Sale	21.75	531,840	11,567,520	1,184,133	Jun 13 04:03 PM
McMaude Michael A	See Remarks	Jun 12 '25	Sale	21.75	119,298	2,594,732	207,590	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Option Exercise	6.37	27,606	175,850	69,999	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Sale	21.75	30,730	668,378	39,269	Jun 13 04:02 PM
Walgreens Boots Alliance, Inc.	Former 10% owner	Feb 18 '25	Sale	21.16	12,000,000	253,920,000	11,239,996	Feb 20 04:30 PM
Walgreen Co.	10% Owner	Feb 18 '25	Proposed Sale	22.15	12,000,000	265,800,000		Feb 18 09:07 PM

Open in Screener

COR

Cencora Inc

Feb 13 • 04:00PM ET

360.83

+9.77 2.78 %

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC ACH PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO IVV SPY VTV XLV IWP VOE VIG

Index	S&P 500	P/E	43.40	EPS (ttm)	8.31	Insider Own	0.42%	Shs Outstand	194.52M	Perf Week	0.44%
Market Cap	70.19B	Forward P/E	18.37	EPS next Y	19.65	Insider Trans	-9.66%	Shs Float	193.71M	Perf Month	3.11%
Enterprise Value	76.49B	PEG	1.69	EPS next Q	4.87	Inst Own	96.32%	Short Float	2.29%	Perf Quarter	-0.71%
Income	1.63B	P/S	0.22	EPS this Y	10.11%	Inst Trans	0.43%	Short Ratio	3.14	Perf Half Y	22.37%
Sales	325.78B	P/B	36.78	EPS next Y	11.52%	ROA	2.20%	Short Interest	4.43M	Perf YTD	6.83%
Book/sh	9.81	P/C	38.81	EPS next 5Y	10.84%	ROE	152.25%	52W High	377.54 -4.43%	Perf Year	47.56%
Cash/sh	9.30	P/FCF	19.46	EPS past 3/5Y	-0.34% -	ROIC	17.13%	52W Low	237.71 51.79%	Perf 3Y	127.50%
Dividend Est.	2.40 (0.66%)	EV/EBITDA	15.86	Sales past 3/5Y	10.43% 11.09%	Gross Margin	3.25%	Volatility	3.63% 3.12%	Perf 5Y	243.06%
Dividend TTM	2.30 (0.64%)	EV/Sales	0.23	EPS Y/Y TTM	18.24%	Oper. Margin	1.16%	ATR (14)	11.44	Perf 10Y	321.48%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	0.51	Sales Y/Y TTM	7.45%	Profit Margin	0.50%	RSI (14)	54.24	Recom	1.55
Dividend Gr. 3/5Y	6.14% 5.79%	Current Ratio	0.92	EPS Q/Q	14.47%	SMA20	1.58%	Beta	0.69	Target Price	406.80
Payout	27.63%	Debt/Eq	4.15	Sales Q/Q	5.45%	SMA50	3.98%	Rel Volume	0.69	Prev Close	351.06
Employees	51000	LT Debt/Eq	3.97	Earnings	Feb 04 BMO	SMA200	13.83%	Avg Volume	1.41M	Price	360.83
IPO	Apr 04, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.77% -0.15%	Trades		Volume	974,990	Change	2.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-29-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$400
Jan-22-26	Upgrade	Jefferies	Hold → Buy	$440
Dec-09-25	Initiated	Barclays	Overweight	$400
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral

Show Previous Ratings

Feb-13-26 04:15PM	Cencora Closes $3.0 Billion Senior Notes Offering (Business Wire)
Feb-11-26 11:37PM	1 Momentum Stock with Impressive Fundamentals and 2 We Question (StockStory)
12:36AM	5 Revealing Analyst Questions From Cencora's Q4 Earnings Call (StockStory)
Feb-10-26 05:15PM	Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 (Business Wire)
07:31AM	What Are Wall Street Analysts' Target Price for Cencora Stock? (Barchart)
09:28AM	Loading…
Feb-06-26 09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
Feb-05-26 03:31PM	Cencora (COR) Stock Trades Up, Here Is Why (StockStory) +6.72%
01:58PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
10:35AM	Analyst Report: McKesson Corporation (Morningstar Research)
01:13AM	Cencora Q1 Earnings Call Highlights (MarketBeat)
12:34AM	COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts (StockStory)
Feb-04-26 11:42PM	Analyst Report: McKesson Corporation (Morningstar Research) -8.79%
04:05PM	Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges (GuruFocus.com)
01:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:59AM	Loading…
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:32AM	Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss (Benzinga)
11:12AM	Rotation out of Tech Stocks Weighs on the Broader Market (Barchart)
10:04AM	Cencora (COR) Q1 2026 Earnings Call Transcript (Motley Fool)
10:03AM	Stocks Mixed on Sector Rotation out of Tech (Barchart)
09:30AM	Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:40AM	Cencora (COR) Q1 Earnings Top Estimates (Zacks)
06:47AM	Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates (StockStory)
06:38AM	Cencora: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2026 First Quarter Results (Business Wire)
Feb-02-26 10:06PM	Cencora (COR) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 09:36AM	Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum (Insider Monkey)
Jan-30-26 09:15AM	Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-26 09:35AM	First Solar downgraded, Fortinet upgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Loading…
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-27-26 08:09PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Jan-26-26 01:27PM	IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' And Not Over Yet (Investor's Business Daily)
Jan-25-26 04:46AM	Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI (Investing.com)
Jan-22-26 07:30AM	Cencora Elects Ellen Cooper to Its Board of Directors (Business Wire)
Jan-12-26 07:51AM	3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds (Zacks)
Jan-09-26 09:06AM	What to Expect From Cencora's Next Quarterly Earnings Report (Barchart)
Jan-08-26 08:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
Jan-07-26 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Jan-06-26 04:30PM	Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release (Business Wire)
Jan-05-26 01:44PM	McKesson Builds Earnings Momentum on Specialty and Automation (Zacks)
Dec-30-25 07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 10:17AM	Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus (Zacks)
08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Dec-24-25 10:36PM	Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks (StockStory)
09:11AM	These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 (Zacks)
Dec-23-25 02:09PM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
09:35AM	Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora (Zacks)
Dec-22-25 10:40AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
Dec-19-25 02:14PM	Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" (Insider Monkey)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-17-25 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-16-25 03:52AM	Cencora takes majority stake in cancer care platform OneOncology for $5B (Healthcare Dive)
Dec-15-25 08:01PM	Lightning Round: Sell BP, says Jim Cramer (CNBC TV)
02:50PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
07:00AM	Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology (Business Wire)
Dec-10-25 08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Dec-09-25 09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-05-25 11:30AM	Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? (Zacks)
Dec-03-25 03:26PM	Why Cencora (COR) Shares Are Trading Lower Today (StockStory)
02:59PM	JPMorgan Raises Cencora (COR) Price Target After Financial Model Update (Insider Monkey)
03:35AM	How Is Cencoras Stock Performance Compared to Other Medical Stocks? (Barchart)
Dec-02-25 12:00PM	Cencora (COR) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Dec-01-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
09:20AM	Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus (Zacks)
Nov-28-25 07:08AM	CVS Health Delivers MBR Improvement: Is More Progress in the Cards? (Zacks)
Nov-26-25 09:09AM	GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows (Zacks)
Nov-25-25 09:50AM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
Nov-24-25 09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-21-25 09:40AM	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? (Zacks)
Nov-18-25 09:15AM	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-17-25 08:40AM	Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus (Zacks)
Nov-14-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Nov-13-25 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Nov-12-25 12:36AM	The 5 Most Interesting Analyst Questions From Cencora's Q3 Earnings Call (StockStory)
Nov-11-25 04:51AM	Cencora Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-07-25 09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-06-25 04:45PM	Cencora makes $1 billion investment in pharma supply chains (FreightWaves)
06:21AM	Cencora to invest $1bn in US pharma distribution network (Pharmaceutical Technology)
12:34AM	COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus (StockStory)
Nov-05-25 09:36PM	Analyst Report: McKesson Corporation (Morningstar Research)
04:00PM	Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ... (GuruFocus.com)
02:59PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:54AM	Rigetti Computing to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
10:56AM	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves (Zacks)
09:30AM	Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:40AM	Cencora (COR) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:00AM	Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain (The Wall Street Journal)
06:44AM	Cencora's (NYSE:COR) Q3 Sales Top Estimates (StockStory)
06:39AM	Cencora: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results (Business Wire)
Nov-04-25 06:35PM	Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:39AM	Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock? (Zacks)
08:39AM	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mauch Robert P.	President & CEO	Jan 20 '26	Option Exercise	86.09	3,763	323,957	71,822	Jan 22 04:43 PM
Mauch Robert P.	President & CEO	Jan 20 '26	Sale	354.73	5,096	1,807,704	66,726	Jan 22 04:43 PM
Mauch Robert P.	Officer	Jan 20 '26	Proposed Sale	354.73	5,096	1,807,704		Jan 20 11:14 AM
Battaglia Silvana	Executive Vice President	Dec 19 '25	Sale	345.00	1,677	578,565	18,796	Dec 22 04:15 PM
Campbell Elizabeth S	Executive Vice President	Dec 19 '25	Sale	342.10	3,351	1,146,377	23,891	Dec 22 04:15 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Option Exercise	86.09	3,763	323,957	73,155	Dec 22 04:14 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Sale	343.45	5,096	1,750,221	68,059	Dec 22 04:14 PM
Campbell Elizabeth S	Officer	Dec 19 '25	Proposed Sale	342.10	3,351	1,146,377		Dec 19 04:15 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 17 '25	Sale	343.24	4,031	1,383,580	17,154	Dec 19 04:04 PM
Cleary James F	Chief Financial Officer	Dec 17 '25	Option Exercise	86.09	45,154	3,887,308	180,095	Dec 19 04:03 PM
Battaglia Silvana	Officer	Dec 19 '25	Proposed Sale	345.00	1,677	578,565		Dec 19 11:03 AM
Mauch Robert P.	Officer	Dec 18 '25	Proposed Sale	343.45	5,096	1,750,221		Dec 18 09:48 AM
Krikorian Lazarus	Officer	Dec 17 '25	Proposed Sale	343.24	4,031	1,383,580		Dec 17 03:55 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Option Exercise	86.09	3,763	323,957	70,842	Nov 19 05:09 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Sale	366.64	5,096	1,868,397	65,746	Nov 19 05:09 PM
Mauch Robert P.	Officer	Nov 18 '25	Proposed Sale	366.64	5,096	1,868,397		Nov 18 11:43 AM
COLLIS STEVEN H	Former Officer & Director	Nov 18 '25	Proposed Sale	366.64	31,349	11,493,797		Nov 18 10:40 AM
COLLIS STEVEN H	Former Officer & Director	Nov 06 '25	Proposed Sale	355.25	50,000	17,762,554		Nov 06 04:16 PM
Verma Pawan	EVP, Chief Data & Info Officer	Oct 31 '25	Option Exercise	337.81	8,537	2,883,884	8,551	Nov 04 04:15 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Option Exercise	86.09	3,763	323,957	43,037	Oct 21 04:33 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Sale	326.80	5,097	1,665,700	37,940	Oct 21 04:33 PM
COLLIS STEVEN H	Former Officer & Director	Oct 21 '25	Proposed Sale	326.99	31,350	10,251,105		Oct 21 04:16 PM
Mauch Robert P.	Officer	Oct 20 '25	Proposed Sale	326.80	5,097	1,665,700		Oct 20 09:36 AM
Campbell Elizabeth S	Executive Vice President	Oct 01 '25	Sale	313.28	1,886	590,846	12,824	Oct 03 04:01 PM
Campbell Elizabeth S	Officer	Oct 01 '25	Proposed Sale	313.28	1,886	590,846		Oct 01 10:36 AM
Mauch Robert P.	President & CEO	Sep 18 '25	Option Exercise	86.09	3,763	323,957	44,371	Sep 22 04:16 PM
Mauch Robert P.	President & CEO	Sep 18 '25	Sale	290.00	5,097	1,478,130	39,274	Sep 22 04:16 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Option Exercise	86.09	29,350	2,526,742	337,263	Sep 18 03:56 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Sale	289.86	31,350	9,087,142	305,913	Sep 18 03:56 PM
Mauch Robert P.	Officer	Sep 18 '25	Proposed Sale	290.00	5,097	1,478,130		Sep 18 11:54 AM
COLLIS STEVEN H	Director	Sep 16 '25	Proposed Sale	291.55	31,350	9,140,092		Sep 16 10:27 AM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Option Exercise	86.09	12,579	1,082,926	322,492	Aug 20 04:08 PM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Sale	289.98	14,579	4,227,618	307,913	Aug 20 04:08 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Option Exercise	86.09	3,225	277,640	45,576	Aug 20 04:06 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Sale	293.53	4,968	1,458,257	40,608	Aug 20 04:06 PM
COLLIS STEVEN H	Director	Aug 19 '25	Proposed Sale	289.98	14,579	4,227,618		Aug 19 09:51 AM
Mauch Robert P.	Officer	Aug 18 '25	Proposed Sale	293.53	4,968	1,458,257		Aug 18 11:06 AM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Option Exercise	86.09	12,578	1,082,840	324,491	Jul 23 04:30 PM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Sale	292.67	14,578	4,266,543	309,913	Jul 23 04:30 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Option Exercise	86.09	3,225	277,640	47,319	Jul 22 04:23 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Sale	294.11	4,968	1,461,138	42,351	Jul 22 04:23 PM
COLLIS STEVEN H	Director	Jul 22 '25	Proposed Sale	292.67	14,578	4,266,543		Jul 22 09:47 AM
Mauch Robert P.	Officer	Jul 18 '25	Proposed Sale	294.11	4,968	1,461,138		Jul 18 11:44 AM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Option Exercise	86.09	12,579	1,082,926	326,492	Jun 25 04:03 PM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Sale	292.62	14,579	4,266,107	311,913	Jun 25 04:03 PM
COLLIS STEVEN H	Director	Jun 24 '25	Proposed Sale	292.62	14,579	4,266,107		Jun 24 10:21 AM
Battaglia Silvana	Executive Vice President	Jun 18 '25	Sale	297.40	4,077	1,212,520	11,297	Jun 20 04:06 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Option Exercise	86.09	3,225	277,640	49,063	Jun 20 04:04 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Sale	295.30	4,969	1,467,346	44,094	Jun 20 04:04 PM
Lon Greenberg	Board of directors	Jun 18 '25	Proposed Sale	293.20	1,000	293,200		Jun 18 04:40 PM
Battaglia Silvana	Officer	Jun 18 '25	Proposed Sale	297.41	4,077	1,212,520		Jun 18 12:58 PM
Mauch Robert P.	Officer	Jun 18 '25	Proposed Sale	295.30	4,969	1,467,346		Jun 18 09:50 AM
Krikorian Lazarus	SVP & Chief Accounting Officer	May 29 '25	Sale	288.96	3,000	866,881	17,154	Jun 02 04:08 PM
Krikorian Lazarus	Officer	May 29 '25	Proposed Sale	288.96	3,000	866,881		May 29 11:37 AM
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM

GRDN Guardian Pharmacy Services Inc daily Stock Chart

Held by: VTI IWM VXF IWO VTWO VHT XHS JSML ITOT GSSC

Index	RUT	P/E	52.57	EPS (ttm)	0.64	Insider Own	64.49%	Shs Outstand	36.25M	Perf Week	-1.24%
Market Cap	2.12B	Forward P/E	29.74	EPS next Y	1.12	Insider Trans	-3.04%	Shs Float	22.49M	Perf Month	11.05%
Enterprise Value	2.13B	PEG	-	EPS next Q	0.27	Inst Own	33.64%	Short Float	8.16%	Perf Quarter	6.05%
Income	40.24M	P/S	1.52	EPS this Y	155.51%	Inst Trans	1.63%	Short Ratio	6.55	Perf Half Y	40.06%
Sales	1.39B	P/B	11.53	EPS next Y	14.50%	ROA	10.90%	Short Interest	1.83M	Perf YTD	11.20%
Book/sh	2.90	P/C	58.06	EPS next 5Y	-	ROE	25.85%	52W High	37.43 -10.61%	Perf Year	65.32%
Cash/sh	0.58	P/FCF	31.08	EPS past 3/5Y	- -	ROIC	19.06%	52W Low	17.78 88.19%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	26.30	Sales past 3/5Y	15.75% -	Gross Margin	19.74%	Volatility	3.81% 5.18%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.53	EPS Y/Y TTM	146.89%	Oper. Margin	4.26%	ATR (14)	1.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.93	Sales Y/Y TTM	18.68%	Profit Margin	2.90%	RSI (14)	58.84	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.22	EPS Q/Q	108.03%	SMA20	6.48%	Beta	0.84	Target Price	35.00
Payout	-	Debt/Eq	0.19	Sales Q/Q	20.05%	SMA50	8.47%	Rel Volume	0.59	Prev Close	33.15
Employees	3400	LT Debt/Eq	0.15	Earnings	Nov 10 AMC	SMA200	28.28%	Avg Volume	280.08K	Price	33.46
IPO	Sep 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.38% 6.57%	Trades		Volume	165,697	Change	0.94%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-10-25	Initiated	Oppenheimer	Outperform	$30
Oct-21-24	Initiated	Truist	Buy	$22
Oct-21-24	Initiated	Raymond James	Outperform	$21

Feb-12-26 04:30PM	Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference (Business Wire)
Feb-09-26 04:30PM	Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call (Business Wire)
Jan-25-26 08:22PM	Stephens Is Bullish on Guardian Pharmacy Services, Inc. (GRDN) After 2026 Forecast Update (Insider Monkey)
Jan-13-26 04:30PM	Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook (Business Wire)
Jan-07-26 03:39PM	Implied Volatility Surging for Guardian Pharmacy Services Stock Options (Zacks)
04:30PM	Loading…
Dec-15-25 04:30PM	Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference (Business Wire)
Nov-17-25 11:29AM	5 Small-Cap Stocks With Impressive Growth and Upside Potential (MarketBeat)
Nov-12-25 11:18AM	Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast (MarketBeat)
Nov-11-25 03:24PM	Why Guardian Pharmacy Services Stock Was on a Tear Tuesday (Motley Fool) +5.04%
12:02AM	Guardian Pharmacy Services Inc (GRDN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Nov-10-25 05:20PM	Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:20PM	Guardian Pharmacy: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance (Business Wire)
Nov-07-25 07:18AM	Guardian Pharmacy Services Inc (GRDN) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-25 05:45PM	Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates (Zacks)
08:45AM	Loading…
Nov-04-25 08:45AM	Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-03-25 10:00AM	Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-30-25 08:30AM	Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates (Zacks)
Oct-28-25 04:30PM	Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference (Business Wire)
Oct-14-25 04:47PM	Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock (Business Wire)
Oct-06-25 08:30AM	Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call (Business Wire)
Sep-12-25 08:57AM	TSCM U.S. Focus Growth Strategy Added Guardian Pharmacy Services (GRDN) in Q2 (Insider Monkey)
Sep-11-25 08:30AM	Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference (Business Wire)
Sep-01-25 09:55AM	Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Aug-25-25 12:00PM	Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-11-25 06:10PM	Guardian Pharmacy: Q2 Earnings Snapshot (Associated Press Finance) +13.78%
04:05PM	Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance (Business Wire)
Aug-04-25 08:07AM	Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare Pharmacy (Business Wire)
Jul-23-25 08:28AM	Should You Consider Adding Guardian Pharmacy Services (GRDN) to Your Portfolio? (Insider Monkey)
Jul-22-25 04:05PM	Guardian Pharmacy Services, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call (Business Wire)
10:03AM	Loading…
Jun-10-25 10:03AM	Guardian Pharmacy of South Carolina Opens New Headquarters in Charleston to Support Statewide Growth (Business Wire)
Jun-02-25 08:07AM	Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services (Business Wire)
May-22-25 11:15PM	Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock (Business Wire)
May-20-25 04:16PM	Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock (Business Wire) -16.75%
May-14-25 10:03AM	Guardian Pharmacy Services Expands Midwest Long-Term Care Footprint with Wichita, Kansas Pharmacy Acquisition (Business Wire)
May-13-25 03:09AM	Guardian Pharmacy Services Inc (GRDN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
May-12-25 04:23PM	Guardian Pharmacy: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results (Business Wire)
May-08-25 04:05PM	Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations (Business Wire)
Apr-30-25 04:12PM	Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call (Business Wire)
Apr-14-25 10:03AM	Guardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West Virginia (Business Wire)
Apr-08-25 10:03AM	Guardian Pharmacy Services Adds Naples Pharmacy to Further Strengthen Long-Term Care Services in Southwest Florida (Business Wire)
Mar-27-25 06:32AM	Q4 2024 Guardian Pharmacy Services Inc Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Guardian Pharmacy Services Inc (GRDN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Mar-26-25 04:18PM	Guardian Pharmacy: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Mar-22-25 11:00AM	Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings (SeekingAlpha)
Mar-03-25 06:00AM	Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results; Provides 2025 Financial Guidance and Earnings Conference Call Date (Business Wire) -5.45%
Feb-17-25 04:05PM	Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference (Business Wire)
Dec-17-24 09:00AM	Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy (Business Wire)
Nov-12-24 04:41PM	Guardian Pharmacy: Q3 Earnings Snapshot (Associated Press Finance) -10.73%
04:05PM	Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-31-24 08:00AM	Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference (Business Wire)
Oct-30-24 08:00AM	Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call (Business Wire)
Oct-21-24 02:54PM	Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating (Benzinga)
Oct-08-24 09:02AM	Ophir Asset Management's Strategic Acquisition in Guardian Pharmacy Services Inc (GuruFocus.com) +7.51%
Sep-26-24 10:50AM	Healthcare firm Guardian Pharmacy valued at about $880 million in lukewarm NYSE debut (Reuters)
Sep-25-24 09:45PM	Healthcare firm Guardian Pharmacy raises $112 million in US IPO (Reuters)
09:10PM	Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering (Business Wire)

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COSLER STEVEN D	Director	Dec 03 '25	Buy	29.61	3,370	99,786	24,984	Dec 05 04:10 PM
Cardinal Equity Fund, L.P.	Member of 10% owner group	May 27 '25	Sale	20.16	270,958	5,462,513	200,099	Sep 30 04:10 PM
Cardinal Equity Fund, L.P.	Member of 10% owner group	May 28 '25	Sale	20.16	50,305	1,014,149	149,794	Sep 30 04:10 PM
Pharmacy Investors, LLC	Member of 10% owner group	May 27 '25	Sale	20.16	813,318	16,396,491	600,622	Sep 30 04:10 PM
Pharmacy Investors, LLC	Member of 10% owner group	May 28 '25	Sale	20.16	150,998	3,044,120	449,624	Sep 30 04:10 PM
BINDLEY WILLIAM E	Director	May 27 '25	Sale	20.16	3,508,905	70,739,525	2,591,271	May 29 04:15 PM
BINDLEY WILLIAM E	Director	May 28 '25	Sale	20.16	651,454	13,133,313	1,939,817	May 29 04:15 PM
Salentine Thomas J Jr	Director	May 27 '25	Sale	20.16	3,508,905	70,739,525	2,591,271	May 29 04:15 PM
Salentine Thomas J Jr	Director	May 28 '25	Sale	20.16	651,454	13,133,313	1,939,817	May 29 04:15 PM
Ackerman John	Director	May 27 '25	Sale	20.16	1,084,276	21,859,004	200,099	May 29 04:15 PM
Ackerman John	Director	May 28 '25	Sale	20.16	201,303	4,058,268	149,794	May 29 04:15 PM
Burke Fred	See Remarks	May 27 '25	Sale	20.16	747,102	15,061,576	551,724	May 29 04:15 PM
Morris David K	See Remarks	May 27 '25	Sale	20.16	369,212	7,443,314	283,042	May 29 04:15 PM
Burke Fred	See Remarks	May 28 '25	Sale	20.16	138,705	2,796,293	413,019	May 29 04:15 PM
Morris David K	See Remarks	May 28 '25	Sale	20.16	68,547	1,381,908	214,495	May 29 04:15 PM
Forbes Kendall	See Remarks	May 27 '25	Sale	20.16	350,058	7,057,169	268,897	May 29 04:15 PM
Forbes Kendall	See Remarks	May 28 '25	Sale	20.16	64,991	1,310,219	203,906	May 29 04:15 PM
Bindley Capital Partners I, LL	10% Owner	May 27 '25	Sale	20.16	3,508,905	70,739,525	2,591,271	May 29 03:06 PM
Bindley Capital Partners I, LL	10% Owner	May 28 '25	Sale	20.16	651,454	13,133,313	1,939,817	May 29 03:06 PM

PETS

Petmed Express, Inc

CVS

CVS Health Corp

BTSG

BrightSpring Health Services Inc

COR

Cencora Inc

GRDN

Guardian Pharmacy Services Inc

Upgrade your FINVIZ experience